SIAMAB
USPTO Trademark Record · Serial No. 86303690
Trademark details
It was initially claimed by SIAMAB THERAPEUTICS, INC. on 20140609.
That brand applies to the following goods and services:Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Diagnostic kits consisting of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Laboratory chemicals, namely, antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, monoclonal antibodies for treating cancer, immune disorders, inflammation, neoplasms, rare diseases, genetic diseases, inborn error of metabolism and auto-immune diseases, Scientific research; scientific research in the fields of biochemicals, namely, monoclonal antibodies; scientific research in the fields of diagnostic kits, consisting of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; scientific research in the field of laboratory chemicals, namely, antibody reagents used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use.
Currently that trademark is represented by trademark attorney(s): Donna T. Ward.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the SIAMAB trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
